Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Häfner, Heinz
2014.
The Concept of Schizophrenia: From Unity to Diversity.
Advances in Psychiatry,
Vol. 2014,
Issue. ,
p.
1.
Lee, Jimmy
Takeuchi, Hiroyoshi
Fervaha, Gagan
Bhaloo, Amaal
Powell, Valerie
and
Remington, Gary
2014.
Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
European Neuropsychopharmacology,
Vol. 24,
Issue. 10,
p.
1622.
Carbon, Maren
and
Correll, Christoph U.
2014.
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
CNS Spectrums,
Vol. 19,
Issue. S1,
p.
35.
Fervaha, Gagan
Agid, Ofer
McDonald, Krysta
Foussias, George
and
Remington, Gary
2014.
Daily activity patterns in remitted first-episode schizophrenia.
Comprehensive Psychiatry,
Vol. 55,
Issue. 5,
p.
1182.
Sicras-Mainar, Antoni
Maurino, Jorge
Ruiz-Beato, Elena
and
Navarro-Artieda, Ruth
2014.
Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: a population-based study.
BMC Psychiatry,
Vol. 14,
Issue. 1,
Fervaha, Gagan
Duncan, Mark
Foussias, George
Agid, Ofer
Faulkner, Guy E.
and
Remington, Gary
2015.
Effort-based decision making as an objective paradigm for the assessment of motivational deficits in schizophrenia.
Schizophrenia Research,
Vol. 168,
Issue. 1-2,
p.
483.
Fervaha, Gagan
Foussias, George
Agid, Ofer
and
Remington, Gary
2015.
Motivational deficits in early schizophrenia: Prevalent, persistent, and key determinants of functional outcome.
Schizophrenia Research,
Vol. 166,
Issue. 1-3,
p.
9.
Kelly, Deanna L.
Sullivan, Kelli M.
McEvoy, Joseph P.
McMahon, Robert P.
Wehring, Heidi J.
Gold, James M.
Liu, Fang
Warfel, Dale
Vyas, Gopal
Richardson, Charles M.
Fischer, Bernard A.
Keller, William R.
Koola, Maju Mathew
Feldman, Stephanie M.
Russ, Jessica C.
Keefe, Richard S. E.
Osing, Jennifer
Hubzin, Leeka
August, Sharon
Walker, Trina M.
and
Buchanan, Robert W.
2015.
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.
Journal of Clinical Psychopharmacology,
Vol. 35,
Issue. 4,
p.
374.
Fervaha, Gagan
Zakzanis, Konstantine K.
Foussias, George
Agid, Ofer
and
Remington, Gary
2015.
Distress related to subclinical negative symptoms in a non-clinical sample: Role of dysfunctional attitudes.
Psychiatry Research,
Vol. 230,
Issue. 2,
p.
249.
Luther, Lauren
Fukui, Sadaaki
Firmin, Ruth L.
McGuire, Alan B.
White, Dominique A.
Minor, Kyle S.
and
Salyers, Michelle P.
2015.
Expectancies of success as a predictor of negative symptoms reduction over 18 months in individuals with schizophrenia.
Psychiatry Research,
Vol. 229,
Issue. 1-2,
p.
505.
Hartmann-Riemer, Matthias N.
Hager, Oliver M.
Kirschner, Matthias
Bischof, Martin
Kluge, Agne
Seifritz, Erich
and
Kaiser, Stefan
2015.
The association of neurocognitive impairment with diminished expression and apathy in schizophrenia.
Schizophrenia Research,
Vol. 169,
Issue. 1-3,
p.
427.
Heringa, Sophie M.
Begemann, Marieke J.H.
Goverde, Angelique J.
and
Sommer, Iris E.C.
2015.
Sex hormones and oxytocin augmentation strategies in schizophrenia: A quantitative review.
Schizophrenia Research,
Vol. 168,
Issue. 3,
p.
603.
Stricklin, Suzanne
Perry, Luke A
and
Ramson, Dhruvesh
2015.
Mirtazapine (adjunct) versus placebo for schizophrenia.
Cochrane Database of Systematic Reviews,
Foussias, George
Siddiqui, Ishraq
Fervaha, Gagan
Agid, Ofer
and
Remington, Gary
2015.
Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments.
Journal of Psychopharmacology,
Vol. 29,
Issue. 2,
p.
116.
Jaracz, K.
Górna, K.
Kiejda, J.
Grabowska-Fudala, B.
Jaracz, J.
Suwalska, A.
and
Rybakowski, J.K.
2015.
Psychosocial functioning in relation to symptomatic remission: A longitudinal study of first episode schizophrenia.
European Psychiatry,
Vol. 30,
Issue. 8,
p.
907.
Foussias, G.
Siddiqui, I.
Fervaha, G.
Mann, S.
McDonald, K.
Agid, O.
Zakzanis, K.K.
and
Remington, G.
2015.
Motivated to do well: An examination of the relationships between motivation, effort, and cognitive performance in schizophrenia.
Schizophrenia Research,
Vol. 166,
Issue. 1-3,
p.
276.
Favrod, J.
Nguyen, A.
Fankhauser, C.
Frobert, L.
McCluskey, I.
and
Rexhaj, S.
2016.
Outils de la Réhabilitation en Psychiatrie.
p.
127.
Potkin, Steven G.
Loze, Jean-Yves
Forray, Carlos
Baker, Ross A.
Sapin, Christophe
Peters-Strickland, Timothy
Beillat, Maud
Nylander, Anna-Greta
Hertel, Peter
Nitschky Schmidt, Simon
Eramo, Anna
Hansen, Karina
and
Naber, Dieter
2016.
Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate.
International Journal of Neuropsychopharmacology,
p.
pyw093.
Egger, Stephan T.
Vetter, Stefan
Weniger, Godehard
Vandeleur, Caroline
Seifritz, Erich
and
Müller, Mario
2016.
The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia.
Frontiers in Public Health,
Vol. 4,
Issue. ,
Kremen, Lisa C.
Fiszdon, Joanna M.
Kurtz, Matthew M.
Silverstein, Steven M.
and
Choi, Jimmy
2016.
Intrinsic and Extrinsic Motivation and Learning in Schizophrenia.
Current Behavioral Neuroscience Reports,
Vol. 3,
Issue. 2,
p.
144.
Comments
No Comments have been published for this article.